Bluebird’s lead CAR-T cancer cell therapy idecabtagene vicleucel (ide-cel) was last year hit with an FDA refuse-to-file letter, which required additional data on chemistry, manufacturing and ...

bluebird bio has its first ever product approval, getting a green light from the EMA for Zynteglo, its ex vivo gene therapy for the rare blood disorder beta thalassaemia.

The most up-to-date news, transfers and opinion on Cardiff City, who play in League One. You can get the latest Bluebirds updates sent straight to your inbox for free by signing up to our ...

The home of Oxford United on BBC Sport online. Includes the latest news stories, transfers, results, fixtures, video and audio.